London Loves Business, in its coverage of the study, reveals that since 2010, the pharmaceutical industry has been slapped with penalties amounting to $82.8 billion across more than 500 documented cases. These violations encompass issues such as disregarding drug and medical device safety standards, promoting medical products without proper authorization, breaching the False Claims Act, and a range of other transgressions.
Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…
Four decades after its Amsterdam beginnings, Barney’s Farm is marking the milestone with new markets,…
Gallup’s new numbers hold a small, awkward pattern: the Americans most convinced cannabis is bad…
The FDA is seeking outside data and analytics services to better understand how people use…
Male cannabis and hemp plants release huge quantities of it in mid-to-late summer, which happens…
Buried in a 50-page legal brief filed August 17 with a DEA administrative law judge…